Kowalsky Matthew Paul 4
4 · Sigilon Therapeutics, Inc. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Kowalsky Matthew Paul
CHIEF OF STAFF AND CLO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-28+165,000→ 165,000 totalExercise: $1.09Exp: 2033-02-27→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]The options vest as to 25% of the underlying shares of common stock on February 28, 2024, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the options are fully vested.